Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06903546
PHASE4

The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients

Sponsor: Indonesia University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients. The main questions it aims to answer are: \- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works to change LDL and HDL cholesterol level. Participants will: * Take propolis or a placebo, 2 times daily with given dose (1 drops/10 kg/times) every day for 2 months * Visit the sub-district health centre once every 2 weeks for checkups * Get their blood checked before and after intervention

Official title: The Effect of Propolis Administration on Low Density Lipoprotein and High Density Lipoprotein in Diabetic Type 2 Patients in Central Jakarta

Key Details

Gender

All

Age Range

35 Years - 59 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2025-03-18

Completion Date

2025-07-31

Last Updated

2025-04-03

Healthy Volunteers

No

Interventions

DRUG

Propolis drops

The intervention given is propolis drops that are approved by Indonesian Food and Drug Authority

OTHER

Placebo

The given placebo are look-alike substance with no effect

Locations (1)

University of Indonesia Faculty of Biomedical Science

Jakarta, Indonesia